News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Libby Clinic Busy with Mesothelioma Screenings
- American Workers Still Exposed to Mesothelioma-Causing Asbestos
- Mesothelioma Patient Featured on ABC’s BostonMed
- Stand Up 2 Cancer Telethon Scheduled for September 10th – Tune In to Join the Cause to Raise Funds for Mesothelioma and Other Cancers
- All Forms of Asbestos Shown to Cause Mesothelioma
- Mesothelin Finding Could Lead to Early Detection of Mesothelioma
- New York Attorney Calls for International Ban on Mesothelioma-Causing Asbestos
- Protein Can be Reliable for Diagnosing Malignant Mesothelioma
- Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
- Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
News Archives
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
Thursday, March 4, 2010
Researchers from Johns Hopkins have created a test that can identify if and when a tumor is coming back after a patient has undergone initial treatment. Blood tests are compared with the unique genetic cancer sequences from the original tumor to tell whether surgeons removed all of the cancerous cells, whether the cancer has spread to other parts of the body, or whether the cancer is coming back. Called the PARE approach, researchers believe the test could be used to develop biomarkers for any cancer including mesothelioma.
Mesothelioma, an unusual form of cancer caused by exposure to airborne asbestos fibers, often has a complex growth pattern making complete surgical removal a very difficult task. The goal of the surgery is to achieve a macroscopically-complete resection, which refers to the removal of all visible tumor cells. Finding hidden cells can be close to impossible making a test like this critical to the treatment of both pleural mesothelioma and peritoneal mesothelioma.
Led by Victor E. Velculescu, MD, PhD, the team found that each patient’s cancer is unique, which is the key to this new test that may revolutionize cancer treatment. The team identified nine unique tumor characteristic rearrangements at the ends of its chromosomes that together serve as the tumor’s fingerprint. PARE is named for this finding: personalized analysis of rearranged ends.
This test is not yet widely available and the cost, around $5,000 per patient, may be prohibitive to some. Johns Hopkins University holds the patent on PARE.
© MesotheliomaHelp.Net. All Rights Reserved. Reprinting or republication of this article or any portion of its content is permitted but must include the MesotheliomaHelp.Net link.
Labels: mesothelioma, treatments
posted by Nancy Meredith at 8:04 AM
